Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Óscar Fernández | Researchclopedia

Back to researchers

Óscar Fernández

Instituto Pirenaico de Ecología ORCID

359

Works

8,588

Citations

49

h-index

165

i10-index

Research Topics

Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Polyomavirus and related diseases

Affiliations

Consejo Superior de Investigaciones Científicas2011–2015

Swiss Center for Electronics and Microtechnology (Switzerland)2023–2023

University of Nottingham2000–2000

University of California, San Francisco2017–2017

Neurosciences Institute2015–2015

Top Works

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

Giancarlo Comi,Massimo Filippi,et al.

20011,055 citations

Systemic Sclerosis and Related Diseases

Cytokine Signaling Pathways and Interactions

Validation of the Multiple Sclerosis International Quality of Life questionnaire

M.C. Simeoni,Pascal Auquier,et al.

2007191 citations

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial

O. R. Hommes,Per Soelberg Sørensen,et al.

2004183 citations

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid,Michelle Mellion,et al.

2019177 citations

Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis

Esther Byun,Stacy J. Caillier,et al.

2008172 citations

Multiple Sclerosis Risk Variant HLA-DRB1*1501 Associates with High Expression of DRB1 Gene in Different Human Populations

Antonio Alcina,María M. Abad‐Grau,et al.

2012155 citations

Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study

Óscar Fernández,Guillermo Izquierdo,et al.

2018154 citations

Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial

Tomas Olsson,Aaron Boster,et al.

2014149 citations

Interferon regulatory factor 5 (<i>IRF5</i>) gene variants are associated with multiple sclerosis in three distinct populations

Guðrún Kristjánsdóttir,Johanna K. Sandling,et al.

2008146 citations